摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(E)-4-(furan-2-yl)-4-oxobut-2-enoic acid | 117379-47-2

中文名称
——
中文别名
——
英文名称
(E)-4-(furan-2-yl)-4-oxobut-2-enoic acid
英文别名
——
(E)-4-(furan-2-yl)-4-oxobut-2-enoic acid化学式
CAS
117379-47-2
化学式
C8H6O4
mdl
——
分子量
166.133
InChiKey
QVKNVTSRNCZBKB-ONEGZZNKSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    153-155 °C(Solv: isopropanol (67-63-0))
  • 沸点:
    315.4±38.0 °C(Predicted)
  • 密度:
    1.328±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    0.3
  • 重原子数:
    12
  • 可旋转键数:
    3
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    67.5
  • 氢给体数:
    1
  • 氢受体数:
    4

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    (E)-4-(furan-2-yl)-4-oxobut-2-enoic acid 在 sodium tetrahydroborate 作用下, 以 甲醇 为溶剂, 反应 24.17h, 生成 (2S,4R,1'S)-4-(furan-2-yl)-4-hydroxy-2-[(1'-phenylethyl)amino]-butanoic acid
    参考文献:
    名称:
    Crystallisation induced asymmetric transformation (CIAT) in the synthesis of furoylalanines and furylcarbinols
    摘要:
    A new synthesis of enantiomerically highly enriched N-substituted furoylalanines has been developed. This process involves the combination of crystallisation induced asymmetric transformation (CIAT) and a conjugate addition of N-nucleophiles to furoylacrylic acids. Further transformations to furoylalanines and substituted furylcarbinols are also described. (c) 2006 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.tetasy.2006.04.024
  • 作为产物:
    描述:
    4-(2-furyl)-2-hydroxy-4-oxobutanoic acidpotassium hydrogensulfate 作用下, 以 甲苯 为溶剂, 反应 2.5h, 以11.891 g的产率得到(E)-4-(furan-2-yl)-4-oxobut-2-enoic acid
    参考文献:
    名称:
    Crystallisation induced asymmetric transformation (CIAT) in the synthesis of furoylalanines and furylcarbinols
    摘要:
    A new synthesis of enantiomerically highly enriched N-substituted furoylalanines has been developed. This process involves the combination of crystallisation induced asymmetric transformation (CIAT) and a conjugate addition of N-nucleophiles to furoylacrylic acids. Further transformations to furoylalanines and substituted furylcarbinols are also described. (c) 2006 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.tetasy.2006.04.024
点击查看最新优质反应信息

文献信息

  • Substituted 4-oxo-crotonic acid derivatives as a new class of protein kinase B (PknB) inhibitors: synthesis and SAR study
    作者:Changliang Xu、Xiaoguang Bai、Jian Xu、Jinfeng Ren、Yun Xing、Ziqiang Li、Juxian Wang、Jingjing Shi、Liyan Yu、Yucheng Wang
    DOI:10.1039/c6ra24953a
    日期:——
    Protein kinase B (PknB) is an essential serine/threonine protein kinase required for Mycobacterium tuberculosis (M. tb) cell division and cell-wall biosynthesis. A high throughput screen using PknB identified a (E)-4-oxo-crotonic acid inhibitor, named YH-8, which was used as a scaffold for SAR investigations. A significant improvement in enzyme affinity was achieved. The results indicated that the
    蛋白激酶B(PknB)是结核分枝杆菌(M. tb)细胞分裂和细胞壁生物合成所必需的丝氨酸/苏氨酸蛋白激酶。使用PknB进行的高通量筛选鉴定出一种名为YH-8的(E)-4-氧代巴豆酸抑制剂,该抑制剂被用作SAR研究的支架。实现了酶亲和力的显着改善。结果表明,α,β-不饱和酮骨架和“反式”构型对于对抗PknB的活性至关重要。而且具有芳基的化合物,特别是在苯环上具有吸电子取代基的化合物,其效能是YH-8的四倍。
  • Design, synthesis, and bioevaluation of a novel class of (E)-4-oxo-crotonamide derivatives as potent antituberculosis agents
    作者:Jinfeng Ren、Jian Xu、Guoning Zhang、Changliang Xu、LiLi Zhao、XueFu You、Yucheng Wang、Yu Lu、Liyan Yu、Juxian Wang
    DOI:10.1016/j.bmcl.2019.01.001
    日期:2019.2
    A series of novel (E)-4-oxo-2-crotonamide derivatives were designed and synthesized to find potent antituberculosis agents. All the target compounds were evaluated for their in vitro activity against Mycobacterium tuberculosis H37Rv(MTB). Results reveal that 4-phenyl moiety at part A and short methyl group at part C were found to be favorable. Most of the derivatives displayed promising activity against
    设计并合成了一系列新颖的(E)-4-氧代-2-巴豆酰胺衍生物,以寻找有效的抗结核药。评价所有目标化合物的抗结核分枝杆菌H37Rv(MTB)的体外活性。结果表明,发现A部分的4-苯基部分和C部分的短甲基是有利的。大多数衍生物显示出对MTB有希望的活性,MIC为0.125至4 µg / mL。尤其是,发现化合物IIIa16对MTB的MIC最佳活性为0.125μg/ mL,对耐药性临床MTB分离株的MIC最佳为0.05-0.48μg/ mL。
  • Isocyanide-based MCRs: Diastereoselective cascade synthesis of perfluoroalkylated pyrano[3,4-c]pyrrole derivatives
    作者:Shanxue Yang、Lan Yao、Zhenhua Fan、Jing Han、Jie Chen、Weimin He、Hongmei Deng、Min Shao、Hui Zhang、Weiguo Cao
    DOI:10.1016/j.jfluchem.2021.109723
    日期:2021.3
    The highly diastereoselective synthesis of perfluoroalkyl-containing pyrano[3,4-c]pyrroles has been accomplished via a cascade process involving Michael addition, Passerini-type reaction, Mumm rearrangement and an oxo-Diels–Alder reaction. This domino transformation of isocyanides, methyl perfluoroalk-2-ynoates and 3-aroyl (or heteroyl) acrylic acids proceeded smoothly at room temperature and led to
    含全氟烷基的吡喃并[3,4- c ]吡咯的高度非对映选择性合成是通过级联过程完成的,该过程涉及迈克尔加成,Passerini型反应,Mumm重排和羰基-狄尔斯-阿尔德反应。异氰酸酯,全氟烷-2-甲基丙烯酸甲酯和3-芳酰基(或杂芳基)丙烯酸的多米诺骨转化在室温下平稳进行,并导致形成具有高官能团相容性的高非对映选择性目标化合物,并具有良好的产率。
  • A simple, diversity oriented synthesis of highly substituted pyridines
    作者:Katarzyna Kaczanowska、Holger Eickhoff、Klaus Albert、Karl-Heinz Wiesmüller、Arnaud-Pierre Schaffner
    DOI:10.1002/jhet.614
    日期:2011.7
    A particularly straightforward and efficient protocol for the synthesis of highly substituted pyridines, based on a condensation reaction of β‐aminocrotonitrile and easily accessible (E)‐2‐oxo‐4‐aryl‐but‐3‐enoic acids and (E)‐4‐oxo‐4‐aryl‐but‐2‐enoic acids is described. J. Heterocyclic Chem., (2011).
    基于β-氨基丁腈和容易获得的(E)-2-氧代-4-芳基-丁-3-丁烯酸和(E)-4的缩合反应,用于合成高度取代的吡啶的特别简单有效的方法描述了-氧--4-芳基-丁-2-烯酸。J.杂环化​​学。(2011)。
  • Mercaptoacyldihydropyrazole carboxylic acid derivatives
    申请人:E. R. Squibb & Sons, Inc.
    公开号:US04254267A1
    公开(公告)日:1981-03-03
    Hypotensive activity is exhibited by compounds having the formula ##STR1## wherein: R.sub.1 is hydrogen, alkyl, aryl, arylalkyl or ##STR2## wherein R.sub.5 is alkyl or aryl; R.sub.2 is hydrogen, alkyl, or haloalkyl; R.sub.3 is furanyl, thienyl or pyridyl; R.sub.4 is hydrogen, alkyl or arylalkyl; and n is 0, 1 or 2.
    具有以下公式##STR1##的化合物表现出降压活性:其中:R.sub.1是氢、烷基、芳基、芳基烷基或##STR2##其中R.sub.5是烷基或芳基;R.sub.2是氢、烷基或卤代烷基;R.sub.3是呋喃基、噻吩基或吡啶基;R.sub.4是氢、烷基或芳基烷基;n为0、1或2。
查看更多